Webinar | May 16, 2024

Addressing The Options And Challenges In Subvisible Particulate Contamination Monitoring In Single Use Systems

This presentation emphasizes the significance of minimizing particulate contamination in pharmaceutical and biopharmaceutical products produced through the use of single-use systems (SUS). The contamination can be categorized into visible and subvisible particles, with the latter being more readily detectable through automated techniques. Mark Bumiller, Technology Manager, Entegris, Inc., outlines a method for testing subvisible particulate contamination, and the obtained results demonstrate that data on submicron particles below specified limits offer valuable insights into the cleanliness levels of the products. For cell and gene therapy products that cannot employ a final sterilizing grade filter, it is advisable to select SUS with cleanliness levels that surpass regulatory requirements to guarantee the safety, potency, and quality of the therapeutics.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online